CHINA MEDICAL SYSTEM HOLDINGS LIMITED
CMS is a specialty pharmaceutical company based in China, focusing on marketing, promotion and sales of prescription drugs and other medicinal products to all therapeutic departments in hospitals nation-wide. CMS builds up its product portfolio for its target markets by asset acquisition, equity investment, licensing-in and distribution partnership on the global basis as well as in-house R&D.
CHINA MEDICAL SYSTEM HOLDINGS LIMITED
Industry:
Pharmaceutical
Founded:
1995-01-01
Address:
Shenzhen, Guangdong, China
Country:
China
Website Url:
http://www.en.cms.net.cn
Total Employee:
1+
Status:
Active
Technology used in webpage:
SPF SSL By Default Content Delivery Network ASP.NET IIS DMARC ASP.NET 4.0 GoDaddy SSL IIS 8 IIS 7
Similar Organizations
Takeda Oncology
Takeda Oncology is a leading biopharmaceutical company.
Stock Details
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-01-14 | Gelesis | China Medical System Holdings Limited investment in Post-IPO Equity - Gelesis | 100 M USD |
| 2017-09-04 | Destiny Pharma | China Medical System Holdings Limited investment in Venture Round - Destiny Pharma | 8 M USD |
Official Site Inspections
http://www.en.cms.net.cn
- Host name: 43.254.157.217
- IP address: 43.254.157.217
- Location: China
- Latitude: 34.7725
- Longitude: 113.7266
- Timezone: Asia/Shanghai
Cannot get whois informations of this domain!!!
More informations about "China Medical System Holdings Limited"
China Medical System Holdings Limited - Crunchbase
En.cms.net.cn/ 491,040; Highlights. Investments 5. obfuscated. Exits . Unlock for free . ... CMS is a specialty pharmaceutical company based in China, focusing …See details»
CMS Overview – CMS - web.cms.net.cn
EN; CN; CMS Overview. ... product and grow it into a market leading position which is evidenced by our over 20% CAGRs of net profit and revenue over the past 15 years (2009-2023). Each …See details»
Innovation - web.cms.net.cn
IND Approval: CMS’s Self-developed Innovative Drug Dual Agonist of Glucagon-like Peptide-1 Receptor/Glucagon Receptor CMS-D005 is Approved for Drug Clinical Trials Partnering We …See details»
en.cms.net.cn
We would like to show you a description here but the site won’t allow us.See details»
Investor Communication – CMS
On 28 September 2010, CMS was listed on the Main Board of the Stock Exchange of Hong Kong Ltd. (stock code: 867) What is the main business of CMS? CMS is a platform company linking …See details»
China Medical System Holdings - Datanyze
Www.cms.net.cn . Contact Information. Headquarters. 6f-8f Block B Majialong Chuangxin Building 198 Daxin Rd, Shenzhen, Guangdong, 518052, China +86 75582416868. China Medical …See details»
China Medical System Holdings Ltd: Overview - GlobalData
Website www.cms.net.cn Telephone 86 755 82416868. No of Employees 5,454. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange 867 (HKG) Revenue (2023) …See details»
China Medical System Holdings Limited | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Investors – CMS - web.cms.net.cn
EN; CN; Investors. About Us. China Medical System Holdings Limited (“CMS” or the “Group”, stock code: 867.HK) is a platform company linking pharmaceutical innovation and …See details»
China Medical System （867.HK） Reincluded in S&P Global
SHENZHEN, CHINA, July 16, 2024 (GLOBE NEWSWIRE) -- In July 2024, China Medical System Holdings Limited (“CMS” or the “Group”) has once again been...See details»
China Medical System: New Drug Application for Vitiligo …
SHENZHEN, Sept 24, 2024 - (ACN Newswire) - China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) is pleased to announce that …See details»
CMS
Feb 8, 2024 China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia. China Medical System Holdings Limited …See details»
China Medical System Holdings Ltd. - synapse.zhihuiya.com
了解China Medical System Holdings Ltd. (康哲藥業控股有限公司)公司的药物管线，治疗领域，技术平台，以及它的43项临床试验, 1篇新闻和11篇文献，疾病领域:神经系统疾病，感染，肿 …See details»
China based CMS joins BaseLaunch as latest partner - PR Newswire
BASEL, Switzerland, Sept. 22, 2021 /PRNewswire/ -- BaseLaunch, the Basel Area-based biotech venture accelerator and incubator, today announces that China Medical System Holdings …See details»
CMS Biotech Pte Ltd - Crunchbase Company Profile & Funding
Organization. CMS Biotech Pte Ltd . Connect to CRM . Save . Summary. People. Signals & News. About. A subsidiary of China Medical System Holdings Limited. Private; en.cms.net.cn/ …See details»
Corporate Governance – CMS
CMS adheres to high standards of corporate governance and strives to maximize long-term shareholder value. We have built a well-established corporate governance structure, in which …See details»
China - The World Factbook
Dec 23, 2024 Net migration rate. comparison ranking: 100. Population distribution. Urbanization. total population growth rate v. urban population growth rate, 2000-2030 ... International …See details»
Leadership – CMS - web.cms.net.cn
互联网药品信息服务资格证书编号：（粤）-非经营性-2021-0109| 粤icp备18157737号| 粤公网安备 44030502003605号See details»
Social Responsibility – CMS
CMS Corporate Responsibility | Supporting the Implementation of “Canteen for Elderly” and “Public Library” Public Welfare Programs. On June 21, 2024, China Medical System Holdings …See details»
News – CMS - web.cms.net.cn
Nov 27, 2024 CMS-D005 CMS-D005 is a highly active and selective dual agonist of glucagon-like peptide-1 receptor (GLP-1R) and glucagon receptor (GCGR). Activating glucagon-like …See details»